We report a case of an axillary abscess with Streptococcus pyogenes complicated by venous thrombosis. Bacterial etiology and typing were obtained by PCR and sequencing of the 16S rRNA and M-protein genes from abscess material. The bacterium was of serotype M41, and serology indicated that it had expressed procoagulant factors.
plain X-ray of the shoulder showed degenerative changes in the acromio-clavicular joint, and ultrasonographic examination of the axilla was normal, with no signs of edema in the musculature or in the subcutaneous layer and no signs of abscess. A slight improvement occurred over the following days. Renewed blood cultures taken at the time of admission turned out negative. On the 6th day after admission, a swelling of the left arm developed and venous flebography confirmed the presence of a venous thrombosis in the axillary vein. Coagulation tests were done and showed a PT(INR) of 1.1, an aPTT of 40 s, and a platelet count of 430 ϫ 10 9 /liter. Low-molecularweight heparin and warfarin treatment was initiated. A magnetic resonance imaging (MRI) scan revealed a multilobulated lesion of 7 by 4 by 7 cm in the left axilla approximately 1.5 cm from the skin enclosing the axillary vein with a contrast signal in the periphery and surrounding edema (Fig. 1A) . A renewed ultrasonographic examination could visualize the abscess, which was punctured led by a computed tomography scan. Abscess material was added to an anaerobic blood culture bottle (BacT/Alert). Direct cultures were negative, and no growth in the bottle was detected.
Abscess material was also subjected to PCR amplification of the 16S rRNA gene and subsequently of the emm gene. DNA was extracted from 200 l of abscess material using Bio Robot EZ-1 with a DNA Tissue kit (Qiagen, Hilden, Germany) after treatment with proteinase K according to the instructions of the manufacturer. Amplification was carried out in a 50-l reaction mixture containing 1ϫ PCR buffer (Qiagen), 3 mM MgCl 2 , 200 M each deoxynucleoside triphosphate, 1.0 U of HotStarTaq DNA polymerase (Qiagen), 10 pmol of each primer, and 5 l of template. P515f (5Ј-TGCCAGCMGCCG CGGTWAT-3Ј [12] ) and P1067r (5Ј-AACATYTCACRACA CGAGCT-3Ј[this study]) were used as PCR and sequencing primers. A pre-PCR step of 15 min at 95°C was followed by 40 cycles of 93°C for 50 s, 52°C for 50 s, and 72°C for 50 s. A final step of 5 min at 72°C terminated the amplification. Tubes with no target DNA and Escherichia coli DNA were included as negative and positive controls, respectively. Both strands of the approximately 520-bp PCR product were sequenced using the BigDye Terminator Cycle Sequencing kit (Applied Biosystems Inc., Foster City, CA) and analyzed on an ABI PRISM 3100
Genetic Analyzer (Applied Biosystems Inc.) by BMLabbet (Furulund, Sweden). The sequence was identical (523/523 bp) to the 16S rRNA gene of Streptococcus pyogenes available at the National Center for Biotechnology Information (www.ncbi .nlm.nih.gov).
The emm gene encoding the S. pyogenes M protein was amplified from abscess material, as described above, using primers derived from conserved parts of the emm1 gene (5Ј-GCTTAGAAAATTAAAAACAGG-3Ј [emm for] and 5Ј-GC GTTTTACAACTGCTGC-3Ј[emm rev]). A 1.2-kbp fragment was generated, and sequencing, as described above, with emmfor yielded a sequence which was highly similar (596/598 bp) to the hypervariable part of the emm41 gene. These results are strongly suggestive of S. pyogenes serotype M41 as the causative agent, and treatment with clindamycin was continued for a total of 3 weeks. The patient had an uncomplicated recovery.
Antibodies directed toward the variable part of the cell wallattached M protein of S. pyogenes are believed to confer serotype-specific protection. Stored serum samples obtained from the patient several years before the present episode were available, and levels of immunoglobulin G (IgG) antibody against S. pyogenes PAM (plasminogen-binding group A streptococcal M-like protein), an M-like protein expressed by serotype M41 (19) , and other virulence determinants in these samples were compared to IgG antibody levels in convalescence-phase sera. ELISA (enzyme-linked immunosorbent assay) was performed essentially as described previously (2) . The following S. pyogenes antigens were used for coating: PAM at 0.5 g/ml, GRAB (protein G-related ␣ 2 M-binding protein) at 0.8 g/ml, IdeS (IgG-degrading enzyme of S. pyogenes) at 1.1 g/ml, SpeB (the secreted streptococcal cysteine proteinase) at 0.5 g/ml, and SclA and SclB (streptococcal collagen-like proteins A and B, respectively, both from serotype M41) at 4 g/ml. Antigens were purified as described previously (2, 13, 19) . Serum samples were diluted 1:500 (PAM, GRAB, IdeS, and SpeB) or 1:50 (SclA and SclB). All antigens gave an absorbance of at least 0.5 when tested with Octagam (human IgG at 50 mg/ml; Octapharma) or a positive-control serum at the same dilutions as the patient serum samples. There was a marked increase in the levels of IgG antibodies against PAM, a collagen-like surface protein (SclB), and SpeB, whereas levels of IgG antibodies against other streptococcal surface proteins remained unchanged (Fig. 1B) . Anti-streptolysin O and anti-DNase B antibody levels on day 21 of illness were elevated.
S. pyogenes, or group A Streptococcus
, is an important human pathogen causing a variety of diseases ranging from mild skin infections like impetigo to life-threatening necrotizing fasciitis and toxic shock-like syndrome. Soft-tissue infections caused by S. pyogenes, such as erysipelas and cellulitis, are characterized by diffuse spreading of inflammation in the tissue. The bacterium also causes tonsillitis, and following this infection, abscess formation in the peritonsillar and pharyngeal tissues is relatively common. Abscess formation at other sites occurs rarely. Cases of abscesses with S. pyogenes in the brain (6, 7, 9, 17) , in the epidural space (10, 16) , in the mediastinum (5), in the lung (8) , in the spleen (4), in the retroperitoneum (11) , in the pericolic tissue (15) , in muscular tissue (1, 3, 18) , and in periprosthetic breast tissue (14) have been reported. Considering how common S. pyogenes infections are, abscess formation at sites other than those around the tonsils is distinctly uncommon. To our knowledge, this is the first reported case with an axillary abscess due to S. pyogenes. Though no signs of erysipelas or lymphangitis were present, we believe that the bacteria entered through the skin and spread to the axillary lymph nodes.
The complicating venous thrombosis, which drew attention to the abscess, was probably due to compression of the axillary vein by the abscess. A previous report (3) of an abscess with S. pyogenes causing venous thrombosis also indicated vein compression as the pathogenetic mechanism behind thrombosis formation. However, S. pyogenes binds many components of the coagulation system and the M41 serotype expresses the SclA and SclB proteins, which recruit thrombin-activatable fibrinolysis inhibitor to the bacterial surface (13) . By serology, we could show that SclB was expressed during the infection, which could mediate a more procoagulatory state at the site of infection. This molecular mechanism may also have contributed to the thrombosis seen.
The use of 16S PCR and sequencing was invaluable for correct diagnosis in this case, as all cultures were negative. This We have no conflicts of interest to report.
